Evidence map›Paper›PMID 33819817›Full record

ArticleEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology2021

Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis.

Gregory P Strauss, Raktima Datta, William Armstrong, Ian M Raugh, Nina V Kraguljac, Adrienne C Lahti

Abstract read
In one paragraph

Article in European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Diminished differentiation of rewards in individuals at clinical high-risk for psychosis.European archives of psychiatry and clinical neuroscience · 2024
    Article
  6. Article
  7. Reinforcement learning deficits exhibited by postnatal PCP-treated rats enable deep neural network classification.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gregory P StraussDepartment of Psychology, University of Georgia, 125 Baldwin St., Athens, 30602 GA, USA. Electronic address: gstrauss@uga.edu.
Raktima DattaDepartment of Psychiatry and Behavioral Neurology, University of Alabama at Birmingham, USA.
William ArmstrongDepartment of Psychiatry and Behavioral Neurology, University of Alabama at Birmingham, USA.
Ian M RaughDepartment of Psychology, University of Georgia, 125 Baldwin St., Athens, 30602 GA, USA.
Nina V KraguljacDepartment of Psychiatry and Behavioral Neurology, University of Alabama at Birmingham, USA.
Adrienne C LahtiDepartment of Psychiatry and Behavioral Neurology, University of Alabama at Birmingham, USA.

Funding

Trajectories of treatment response as window into the heterogeneity of psychosis: a longitudinal multimodal imaging study in medication-naieve first episode psychosis patientsR01MH113800 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LAHTI, ADRIENNE C · 2018 to 2022
$3.9M
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation StudyR01MH116039 · NIMH · UNIVERSITY OF GEORGIA · PI MITTAL, VIJAY A, STRAUSS, GREGORY P · 2019 to 2023
$3.1M
Glutamate, brain connectivity and duration of untreated psychosisR01MH102951 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LAHTI, ADRIENNE C · 2014 to 2018
$2.9M
Structural and Neurometabolic White Matter Integrity in the Deficit SyndromeK23MH106683 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KRAGULJAC, NINA VANESSA · 2015 to 2019
$883k
Mechanisms Underlying Emotion Regulation Abnormalities in Youth at Clinical High-Risk for PsychosisR21MH119438 · NIMH · UNIVERSITY OF GEORGIA · PI STRAUSS, GREGORY P · 2019 to 2020
$415k
NIMH NIH HHS K23 MH106683NIMH NIH HHS R01 MH102951NIMH NIH HHS R01 MH113800NIMH NIH HHS R01 MH116039NIMH NIH HHS R21 MH119438
6 · The paper itself

Abstract

Prior studies indicate that chronic schizophrenia (SZ) is associated with a specific profile of reinforcement learning abnormalities. These impairments are characterized by: 1) reductions in learning rate, and 2) impaired Go learning and intact NoGo learning. Furthermore, each of these deficits are associated with greater severity of negative symptoms, consistent with theoretical perspectives positing that avolition and anhedonia are associated with impaired value representation. However, it is unclear whether these deficits extend to earlier phases of psychotic illness and when individuals are unmedicated. Two studies were conducted to examine reinforcement learning deficits in earlier phases of psychosis and in high risk patients. In study 1, participants included 35 participants with first episode psychosis (FEP) with limited antipsychotic medication exposure and 25 healthy controls (HC). Study 2 included 17 antipsychotic naïve individuals who were at clinical high-risk for psychosis (CHR) (i.e., attenuated psychosis syndrome) and 18 matched healthy controls (HC). In both studies, participants completed the Temporal Utility Integration Task, a measure of probabilistic reinforcement learning that contained Go and NoGo learning blocks. FEP displayed impaired Go and NoGo learning. In contrast, CHR did not display impairments in Go or NoGo learning. Impaired Go learning was not significantly associated with clinical outcomes in the CHR or FEP samples. Findings provide new evidence for areas of spared and impaired reinforcement learning in early phases of psychosis.

Indexed as

Antipsychotic AgentsPsychotic DisordersSchizophreniaHumansLearningReinforcement, PsychologyAntipsychotic AgentsClinical high-riskEarly psychosisPsychosis riskReward learningUltra high-risk

Identifiers

PMID33819817
PMCPMC8197752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.